Catalyst Wire Dossier Catalyst Wire Dossier

Anti-C5aR antibody

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-C5aR antibody, covering 2017-02-09 to 2017-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects [Phase 1]

See pricing